In a wide-ranging video interview, Wendie Berg, MD, PhD, discussed her family history with breast cancer, the founding of DenseBreast-info.org, emerging research with contrast-enhanced mammography and the need for a national standard on breast density notifications.
For Wendie Berg, MD, PhD, FACR, FSBI, conducting and disseminating research and education on breast cancer screening has been a driving force in her career and a personal mission as well. Her mother had breast cancer, her aunt had breast cancer and Dr. Berg is a breast cancer survivor. In a recent interview, Dr. Berg emphasized the importance of timely supplemental breast imaging in women with dense breasts.
“It’s very hard when you see a patient who has a cancer that is larger than it needed to be that wasn’t seen on a recent mammogram, and she didn’t know she had dense breasts and didn’t know she could have had additional screening that could have found the cancer earlier,” noted Dr. Berg, a professor of radiology at the University of Pittsburgh. “I’m trying to reduce that from happening to other women.”
In April 2015, Dr. Berg co-founded www.DenseBreast-info.org, which provides patient-oriented and provider-focused resources on dense breasts, a key risk factor for the development of breast cancer. On the recent World Dense Breast Day (September 28, 2022), Dr. Berg said the website had a reach of over 8 million people on social media platforms with visits from 37 countries and over 17,000 content engagements.
One of the leading researchers on breast imaging, Dr. Berg said contrast-enhanced mammography is a promising advance that can help detect breast cancer that may not be apparent on digital mammography. She also noted that contrast-enhanced mammography has practical advantages as it can be performed with existing equipment, minimal software upgrades and contrast that is inexpensive.
For more insights from Dr. Berg, watch the video below.
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
Multicenter Study Shows Merits of AI-Powered Ultrasound Assessment for Detecting Ovarian Cancer
January 3rd 2025Adjunctive AI offered greater than seven percent increases in sensitivity, specificity, and accuracy for ultrasound detection of ovarian cancer in comparison to unassisted clinicians who lacked ultrasound expertise, according to findings from new international multicenter research.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.